Pipeline Update: Four IPOs on the Schedule; Filings trickle in

NEW FILINGS

Company: Kyverna Therapeutcs, Inc.

Symbol: KYTX (Nasdaq)

Description: They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.

Shares: TBD

Price Range: TBD

Trade Date:  TBD

Underwriters: JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo

Link to Prospectus: Filed: 1-16-24

Company: BBB Foods Inc.

Symbol: TBBB (NYSE)

Description: They are pioneers and leaders of the grocery hard discount model in Mexico and one of the fastest growing retailers in the country as measured by our sales and store growth rates.

Shares: TBD

Price Range: TBD

Trade Date:  TBD

Underwriters: JP Morgan, Morgan Stanley, BofA Securities, ScotiaBank, UBS Investment Bank

Link to Prospectus: Filed: 1-18-24

 

 

TERMS ADDED:

Company: CG Oncology, Inc

Symbol: CGON (Nasdaq)

Description: They are a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.

Shares: 11.8 million

Price Range: $16.00-$18.00

Market Cap: $885m-$1.0b

Trade Date:  Thursday, 1/25

Underwriters: Morgan Stanley, Goldman Sachs, Cantor

Co-Managers: LifeSci Capital

Link to Prospectus: Terms Added: 1-18-24

 

 

Company: BrightSpring Health Services, Inc.

Symbol: BTSG (Nasdaq)

Description: They are a leading home and community-based healthcare services platform, focused on delivering complementary provider and pharmacy services to complex patients.

Shares: 53.3 million

Price Range: $15.00-$18.00

Market Cap: $2.6b-$3.1b

Trade Date:  Friday, 1/26

Underwriters: Goldman Sachs, KKR, Jefferies, Morgan Stanley, UBS, BofA Securities, Leerink Partners, Wells Fargo, Deutsche Bank, HSBC, Mizuho, BMO Capital Markets, Loop Capital Markets

Link to Prospectus: Terms Added: 1-17-24

 

 

Company: Morgan Stanley Direct Lending Fund

Symbol: MSDL (NYSE)

Description:  They are a non-diversified, externally managed specialty finance company focused on lending to middle-market companies.

Shares: 5.0 million

Price Range: $20.67-$20.67

Market Cap: $1.8b-$1.8b

Trade Date:  Thursday, 1/25

Underwriters: Morgan Stanley, JP Morgan,  Wells Fargo, Keefe Bruyette & Woods, Raymond James, RBC Capital, UBS Investment Bank

Co-Manager(s): ING, JMP Securities, MUFG, SMBC  Nikko, Academy Securities, Loop Capital, R Seelaus & Co., Ramirez & Co.

Link to Prospectus:  Filed: 1-16-24

 

Company: Nuveen Churchill Direct Lending Corp.

Symbol: NCDL (NYSE)

Description:  They are a specialty finance company focused primarily on investing in senior secured loans to private equity-owned U.S. middle market companies.

Shares: 5.5 million

Price Range: $18.05-$18.05

Market Cap: $990m-$990m

Trade Date:  Thursday, 1/25

Underwriters: BofA Securities, UBS Investment Bank, Morgan Stanley, Wells Fargo, Keefe Bruyette & Woods, JMP Securities, Truist Securities

Co-Manager(s): MUFG, SMBC Securities, Academy Securities, Blaylock Van LLC

Link to Prospectus:  Filed: 1-16-24

Pipeline Update: Four IPOs on the Schedule; Filings trickle in
Scroll to top
error: Content is protected !!